CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Planned sale Director sold 46,534 shares at $30.05 ($1,398,347)
- 4 Planned sale 10% owner sold 46,534 shares at $30.05 ($1,398,347)
- 4 Planned sale CEO & President sold 100,000 shares at an average $28.96 ($2,895,519)
- 4 Planned sale Chief Business Officer sold 28,528 shares at an average $28.46 ($811,865)
- 4 Planned sale SVP, Head of Finance & Admin. sold 12,740 shares at an average $28.05 ($357,296)
- 4 Planned sale Director sold 807,838 shares at an average $24.30 ($19,626,903)
- 4 Planned sale 10% owner sold 807,838 shares at an average $24.30 ($19,626,903)
- 4 Planned sale Chief Medical Officer sold 407 shares at $25.00 ($10,175)
- 4 Planned sale Director sold 500,789 shares at an average $22.64 ($11,339,780)
- 4 Planned sale 10% owner sold 500,789 shares at an average $22.64 ($11,339,780)
- 4 Planned sale Director sold 510,152 shares at an average $23.26 ($11,867,292)
- 4 Planned sale 10% owner sold 510,152 shares at an average $23.26 ($11,867,292)
- 4 Planned sale Chief Medical Officer sold 5,493 shares at $25.07 ($137,710)
- 4 Gift CEO & President gave 21,500 shares (gift)
- 4 Planned sale Chief Medical Officer sold 100 shares at $25.00 ($2,500)
- 4 Planned sale Chief Business Officer sold 20,000 shares at an average $24.53 ($490,510)
- 4 Planned sale SVP, Head of Finance & Admin. sold 13,000 shares at $24.34 ($316,420)
- 4 Open-market buy Director bought 1,714,285 shares at $17.50 ($29,999,988)
- 4 Planned sale CEO & President sold 269,719 shares at an average $18.66 ($5,032,915)
- 4 Planned sale Chief Scientific Officer sold 87,779 shares at an average $18.57 ($1,629,985)
Page 10 of 19 · 361 filings